There was no significant between-group difference in the prespecified secondary outcomes , randomization-to-delivery interval ( 17.1 16.1 vs 17.0 15.8 days , respectively ; P = .76 ) or composite adverse perinatal outcome ( 63 % vs 61 % , respectively ; P = .93 ) .